z-logo
open-access-imgOpen Access
Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial
Author(s) -
Saoussen Ben Abdallah,
Yosra Mhalla,
Imen Trabelsi,
Adel Sekma,
Rim Youssef,
Khaoula Bel Haj Ali,
Houda Ben Soltane,
Hajer Yacoubi,
Mohamed Amine Msolli,
Nejla Stambouli,
Kaouthar Beltaïef,
Mohamed Habib Grissa,
Meriem Khrouf,
Zied Mezgar,
C. Loussaief,
Wahid Bouida,
Rabie Razgallah,
Karima Hezbri,
Asma Sriha Belguith,
Naouel Belkacem,
Zohra Dridi,
Hamdi Boubaker,
Riadh Boukef,
Semir Nouira
Publication year - 2022
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac807
Subject(s) - medicine , placebo , randomization , randomized controlled trial , intensive care unit , comorbidity , adverse effect , clinical endpoint , ambulatory , alternative medicine , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom